| Class 2 Device Recall Viatron TSeries Dual Chamber pacemakers | |
Date Initiated by Firm | February 05, 2007 |
Date Posted | July 07, 2007 |
Recall Status1 |
Terminated 3 on October 16, 2008 |
Recall Number | Z-1000-2007 |
Recall Event ID |
37587 |
Product Classification |
Pacemakers - Product Code NVZ
|
Product | Vitatron T-Series Dual Chamber pacemaker T60 DR, model T60A1. The Vitatron C60 DR is a dual chamber rate responsive pacemaker (activity sensing using an accelerometer) for permanent atrial and ventricular pacing. T-Series software VSF07/VSF08 Version 1.2. Vitatron is a division of Medtronic, Inc., Sales Office is Vitatron USA, 7000 Central Ave., NE, Minneapolis, MN 55423-3576. The head office is Vitatron B.V., P.O. Box 5227, 6802 EE Arnhem, The Netherlands |
Code Information |
All lots/serial numbers |
Recalling Firm/ Manufacturer |
Medtronic Inc. Cardiac Rhythm Managment 7000 Central Ave Ne Minneapolis MN 55432-3568
|
Manufacturer Reason for Recall | Pacing rate: Software anomaly affecting Vitatron dual chamber C-series and T-series pacemakers, related to automatic retrograde conduction testing, can inhibit the device from pacing if the patient's intrinsic rate falls below the programmed lower rate. |
FDA Determined Cause 2 | Software design |
Action | Advisory letters to physicians were mailed in February 2007. Sales respresentatives will follow-up with physicians by visit. A programmer software update will be released upon regulatory approval. The Advisory Letter provided short-term direction to reduce problems pending software upgrades. |
Quantity in Commerce | 6,259 |
Distribution | within the US to include: AL, AR, AZ, CA, CT, FL, GA, IL, IN, KY, MA, MD, MI, MN, NC, ND, NJ, NY, OH, OK, SC, TX. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|